Remap Consulting

🎄✨ Seasons Greetings from all of us at Remap Consulting! As we wrap up the year, we’re excited to celebrate with our Christmas Party and spread the holiday cheer. Thank you for being part of our journey in 2024—here’s to a joyful festive season and a bright year ahead! 🌟

🎉 Introducing the Remap JCA Advisor  At Remap Consulting, we’re all about making the complex simple for our clients. That’s why we’re excited to share the launch of the Remap JCA Advisor, an AI-powered tool designed to help stakeholders better understand the European Union Health Technology Assessment (EU HTA) processes.  This tool aims to simplify the complexities of the Joint Clinical Assessment (JCA) and Joint Scientific Consultation (JSC) processes, offering:  ✅ Clear Guidance: Detailed insights into EU HTA regulations and procedures.  ✅ Curated Knowledge: Reliable information sourced from trusted and up-to-date references.  ✅ Ease of Use: A user-friendly interface for intuitive navigation and seamless information retrieval.  We hope this tool will provide valuable support to those preparing for or engaging with EU HTA requirements.  👉 To learn more and explore the tool contact us contact@remapconsulting.com   We’d love to hear your thoughts as we continue to refine and improve how we support stakeholders in this space. #EUHTA #HealthTech #Innovation 

We are now in our 5th year of this tradition and I really enjoy it. Thanks to you all for supporting and making a massive difference to these charities

🌟 A Heartfelt Thank You from Remap Consulting 🌟 As the festive season approaches, it's time for our cherished annual Remap tradition! We want to take a moment to say a big thank you for all your support over the last 12 months. Your trust and collaboration mean the world to us. In keeping with our annual tradition, we want to express our thanks in a meaningful way. For the fifth consecutive year, we are making charitable donations on behalf of our clients to causes that resonate deeply with us. This year, we will be supporting three remarkable organizations:   -Manchester Mind: In 2024, we have already raised over £650 to support their vital work in mental health. - Médecins Sans Frontières (Doctors Without Borders): Providing life-saving medical care in some of the most challenging environments worldwide. - UNICEF: Supporting children’s health, education, and safety globally.   These charities reflect our values and commitment to making a positive impact, and it’s thanks to your support that we can contribute to these important causes.   On behalf of everyone at Remap Consulting, we would like to personally thank you for an incredible year. We wish you and your loved ones a happy and healthy festive break and a fantastic start to 2025. Here’s to another year of meaningful collaboration and success!

As 2024 comes to an end, it’s the perfect time to reflect on the trends that shaped the world of Pricing & Market Access this year. From evolving payer priorities to the latest in regulatory shifts, the PMA landscape continues to challenge and inspire innovation.  🔗 Read our latest article, where we explore the key trends that defined 2024 and their implications for the future: https://lnkd.in/ejMhyjQ4 What trend stood out the most to you this year? Let us know in the comments! 👇

Exclusive: ISPOR Europe Report 👀🚀 Last week, Remap Consulting joined over 4000 delegates in beautiful Barcelona to explore the theme "𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞 𝐓𝐨𝐰𝐚𝐫𝐝 𝐇𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐖𝐞𝐥𝐥-𝐁𝐞𝐢𝐧𝐠" 🫀 ✅ #ISPOREurope provided valuable insights into key topics shaping the future of health economics and outcomes research (HEOR), including the rollout of EU HTA, the evolving role of real-world evidence, and strategies for aligning evidence requirements across member states. Missed the event?  Don’t worry - we’ve got you covered! Download our comprehensive report jam-packed with highlights and practical takeaways 📖👉 https://lnkd.in/eznPkxdp What stood out to you this year? Share your thoughts below! 💭 #marketaccess #heor #patientaccess #oncology #raredisease #realworldevidence #pharmaceutical #pharma #biotech #healthcare #euhta #jointclinicalassessment

What an incredible three days it's been at ISPOR—The Professional Society for Health Economics and Outcomes Research 2024! 🌟 Our team had an exceptional time, filled with valuable interactions, reunions with clients, colleagues, and friends, and the joy of forging new connections. A huge thank you to everyone who stopped by to see us, and to our team for their fantastic contributions 🙏 👀 Keep an eye out for the full conference report, available next week! 👀 Next on our conference agenda: the World Evidence, Pricing and Access Congress in March 2025. Have questions for our expert team? Drop them in the comments below! 💬 #patientaccess #raredisease #euhta #oncology #realworldevidence #isporeurope #healthcare #pharmaceuticals #NICE Paul Craddy Graham Foxon Mariam Bibi

🌍 𝐀𝐧𝐝 𝐭𝐡𝐚𝐭'𝐬 𝐚 𝐰𝐫𝐚𝐩 𝐟𝐨𝐫 𝐃𝐚𝐲 𝟑! 👏 This afternoon, we attended the final plenary session at #ISPOREurope 2024, "Reality Check: Are We Bridging the Evidence Gaps for Patients?" The discussion highlighted the need for stronger collaboration among stakeholders - regulators, HTA agencies, payers, and the pharmaceutical industry - to generate meaningful and reliable evidence that supports #patientaccess. Key themes included leveraging real-world data and clinical trials to meet diverse evidence needs, reducing uncertainties at every stage of decision-making, and ensuring innovative treatments reach patients as early as possible⚕ Want to know our 𝐤𝐞𝐲 𝐭𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐩𝐥𝐞𝐧𝐚𝐫𝐲? Check out our summary ➡ 𝐏𝐋𝐔𝐒... You can find all of our research and summaries on our 𝐯𝐢𝐫𝐭𝐮𝐚𝐥 𝐛𝐨𝐨𝐭𝐡, and for our newsletter subscribers, you'll receive a full report next week! If you're not a subscriber....sign up!! 👉 https://lnkd.in/exy8iWT6 📰 #marketaccess #heor #globalconference #hta #pharma #healthcare #pharmaceuticals 

🌍 We're halfway through the final day of #ISPOREurope, and the thought of saying goodbye to this event and beautiful city has us feeling a bit disheartened, especially after last night's La Sagrada Familia tour! Our team have had an incredible time meeting you all 🤝 This year's conference has been jam-packed with thought-provoking discussions, in particular surrounding the new EU HTA, sixteen years in the making, coming in just 53 days! We'll be sharing an overview of day 3's plenary session, a little later on 😀 and in the meantime, take a look at our 𝐝𝐚𝐲 𝟐 𝐬𝐮𝐦𝐦𝐚𝐫𝐲➡️ https://lnkd.in/eyT7cxfv Plus, there's still time to meet our incredible team - stop by 📍 𝐛𝐨𝐨𝐭𝐡 𝟏𝟏𝟏𝟑 before you leave Barcelona! #marketaccess #heor #globalconference #isporconference #pharma #raredisease #pharmaceuticals #exhibition #oncology #euhta

🚀 Let us catch you up on 𝐃𝐚𝐲 𝟐 at #ISPOREurope! 👉 https://lnkd.in/eyT7cxfv Devan Hopkinson attended this morning's plenary session, "Ready, Set, Go: The Last Sprint for the EU HTAR," which featured insightful discussions on the upcoming EU Health Technology Assessment Regulation 🌐 The session explored pivotal topics including: ➡️ Readiness for EU HTA implementation, with 30 JCAs expected in 2025 ➡️ The importance of high-quality evidence to reduce uncertainty and support smarter decision-making ➡️ Challenges in managing diverse PICOs across member states and the evolving role of patient advocacy We hope you're finding our updates useful! Our team is at booth 1113 throughout the conference - stop by for a chat or reach out to arrange a meeting. More updates coming your way soon 👀 #marketaccess #HEOR #globalconference #ISPORconference #pharma #patientaccess #EUHTAR